Metformin has been used for more than 60 years as a frontline treatment for type 2 diabetes, but new research suggests the widely prescribed medicine may do more inside the body than previously understood. The latest findings point to an unexpected effect on the brain, adding a new layer to how scientists think about the drug.
The study highlights a broader theme in medicine: even long-established treatments can still hold surprises. Although metformin has been a standard therapy for decades, researchers say there is still much to learn about the way it works beyond its well-known role in helping manage blood sugar.
That makes the reported brain-related effect especially notable. It suggests metformin may influence biological systems outside the areas most commonly linked with diabetes treatment, raising fresh questions about its full mechanism and how its benefits or effects may extend beyond metabolism.
For patients and clinicians, the research does not change the fact that metformin remains one of the most important medicines for type 2 diabetes. But it does underscore why scientists continue to study even the most familiar drugs, especially when new evidence shows they may affect the body — and the brain — in unexpected ways.
